These findings suggest that Wnt/β-catenin and PI3K/AKT signaling work together to regulate PCSC stemness properties and targeting the pathways demonstrated potential therapeutic ways to eradicate prostate cancer. This evidence concerns the gene AKT1 and Familial prostate cancer.